Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Watts

Showing results (881-890 of 928) with videos related to

Pageof 93
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of AβOskar Adolfsson, Maria Pihlgren, Nicolas Toni, et al.
Scientific Reports|April 27, 2019
The risk of selenium deficiency in Malawi is large and varies over multiple spatial scalesFelix P Phiri, E Louise Ander, Elizabeth H Bailey, et al.
Science Translational Medicine|May 27, 2011
A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivoJasvinder K Atwal, Yongmei Chen, Cecilia Chiu, et al.
Nature Communications|September 3, 2024
A molecular mechanism to diversify Ca<sup>2+</sup> signaling downstream of Gs protein-coupled receptorsJulian Brands, Sergi Bravo, Lars Jürgenliemke, et al.
The Journal of Biological Chemistry|January 13, 2017
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in MiceMegan Lo, Hok Seon Kim, Raymond K Tong, et al.
Scientific Reports|March 13, 2013
Soil-type influences human selenium status and underlies widespread selenium deficiency risks in MalawiRachel Hurst, Edwin W P Siyame, Scott D Young, et al.
Journal of Experimental Botany|June 26, 2025
LATERAL BRANCHING OXIDOREDUCTASE specificity for strigolactone branching inhibition in barleyMaiko Inoue, Apriadi Situmorang, Jack H Kelly, et al.
Neuron|December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Journal of Medicinal Chemistry|December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Pageof 93

Showing results (881-890 of 928) with videos related to

Sort By:
Pageof 93
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of AβOskar Adolfsson, Maria Pihlgren, Nicolas Toni, et al.
Scientific Reports|April 27, 2019
The risk of selenium deficiency in Malawi is large and varies over multiple spatial scalesFelix P Phiri, E Louise Ander, Elizabeth H Bailey, et al.
Science Translational Medicine|May 27, 2011
A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivoJasvinder K Atwal, Yongmei Chen, Cecilia Chiu, et al.
Nature Communications|September 3, 2024
A molecular mechanism to diversify Ca<sup>2+</sup> signaling downstream of Gs protein-coupled receptorsJulian Brands, Sergi Bravo, Lars Jürgenliemke, et al.
The Journal of Biological Chemistry|January 13, 2017
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in MiceMegan Lo, Hok Seon Kim, Raymond K Tong, et al.
Scientific Reports|March 13, 2013
Soil-type influences human selenium status and underlies widespread selenium deficiency risks in MalawiRachel Hurst, Edwin W P Siyame, Scott D Young, et al.
Journal of Experimental Botany|June 26, 2025
LATERAL BRANCHING OXIDOREDUCTASE specificity for strigolactone branching inhibition in barleyMaiko Inoue, Apriadi Situmorang, Jack H Kelly, et al.
Neuron|December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Journal of Medicinal Chemistry|December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Pageof 93